+91 9740742752 ||   admissions@hcgcare.org

Dr. Radheshyam Naik

Image

Dr. Radheshyam Naik

Dr. Radheshyam Naik

Dr. Radheshyam Naik is an experienced medical oncologist, and his expertise lies in the management of a broad spectrum of cancers. He has a special interest in haematological disorders and bone marrow transplantation. Dr. Naik’s areas of expertise also include haemato-oncology, stem cell therapy, allogeneic and haploidentical bone marrow transplant, along with the treatment of kidney, prostate, lungs, bones, colorectal and genitourinary cancers.

  • Qualification : MBBS, MD (General Medicine), DM (Medical Oncology)
  • Specialities : Medical Oncology
  • Locations :HCG Cancer Center – KR BLR, HCG Cancer Center – KR BLR

Area of Expertise

  • Experienced medical oncologist specializing in the management of a broad spectrum of cancers.
  • Special interest in haematological disorders and bone marrow transplantation.
  • Expertise in haemato-oncology and stem cell therapy.
  • Skilled in allogeneic and haploidentical bone marrow transplants.
  • Experienced in treating kidney, prostate, lung, bone, colorectal, and genitourinary cancers.

Medical Breakthrough

  • Performed the first intra-arterial chemotherapy using a port.
  • Credited with performing the first Bone Marrow Transplant in Karnataka.
  • Pioneered multiple drug trials, studying over 50 chemotherapy drugs in national and international clinical trials.
  • Authored and co-authored several peer-reviewed publications in leading medical journals.

Awards & Accolades

  • Received advanced training from M.D. Anderson Cancer Institute, USA.
  • Trained at International School for Cancer Care, Oxford, UK.
  • Advanced training at University of New South Wales, Australia.
  • Specialized training at Hadassah University, Israel.
  • Training at Detroit Medical Centre, New York Hospital USA, Cornell Medical Centre, and Harper Hospital, Michigan for bone marrow transplantation.

Publications

  • “Landscape of clinically actionable mutations in breast cancer – A cohort study.” Transl Oncol. 2021 Jan;14(1):100877.
  • “Plasmablastic Lymphoma Involving Kidney in an HIV Positive Patient.” Indian J Nephrol. 2021 Mar-Apr;31(2):176-178.
  • “Hypermagnesemia in critically ill cancer patients: A case report.” Mol Clin Oncol. 2021 Jun;14(6):123.
  • “Addition of Nimotuzumab to Standard TPF Regimen in Head and Neck Cancer.” J Oncol. 2021.
  • “Targeted Therapy Management in NSCLC Patients Using Cytology.” Mol Diagn Ther. 2016 Apr;20(2):119-23.
  • “Genetics and Breast Cancer – Oncologists Perspectives.” Indian J Surg Oncol. 2015 Dec;6(4):415-9.
WhatsApp